SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

Share Price is delayed by 15 minutes
Get Live Data
37.00    -0.50 (-1.33%)
Bid:
36.00
Ask:
38.00
Spread: 2.00 (5.556%)
Market Cap: £8.82m
SWG Live PriceLast checked at - London Stock Exchange

Intraday Shearwater Share Chart

Schedule 1 - Shearwater Group Plc

24 Apr 2017 08:00

RNS Number : 0499D
AIM
24 April 2017
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Shearwater Group plc

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

22 Great James Street

London WC1N 3ES

 

COUNTRY OF INCORPORATION:

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.theshearwatergroup.co.uk

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

In 2016 and 2017, the Company appointed a number of new Directors and have in 2017, assembled an operating team with substantial experience within the high technology, cyber, information security, digital and communications sectors, with a track record of delivering shareholder value through accelerated buy and build processes. The Company intends to leverage this experience to create a UK based group providing digital resilience solutions. In support of this strategy, the Company completed two placings in 2016, raising in excess of £7 million of gross proceeds to help fund initial acquisitions, due diligence exercises and the general operating expenses of the Company.

 

The Company has conditionally agreed to acquire:

 

· The entire share capital of SecureEnvoy Limited, one of the UK's leading providers of multifactor authentication enterprise software solutions (the "Transaction"). SecureEnvoy is headquartered in the UK, with end users across the US, Europe and Australia.

 

The consideration for the Transaction is (i) £10 million in cash and (ii) £10 million of shares in the Company at a price of 5 pence per share.

 

The cash consideration of the Transaction will be financed through existing cash resources in addition to a fundraising consisting of a conditional placing and an open offer (the "Fundraising"). The Transaction and the Fundraising are inter-conditional.

 

The Transaction constitutes a reverse takeover under AIM Rule 14 and accordingly, the Company will seek readmission ("Admission") of its shares to trading on AIM of the London Stock Exchange.

 

The Transaction and associated fundraising will be subject to the passing of relevant resolutions at the Company's general meeting to be held on 8 May 2017.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

Up to 960,738,394 ordinary shares of 1 penny each ("Ordinary Shares") (assuming full take up under the Open Offer)

No shares held in treasury.

No restrictions as to transfer of the securities.

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

Capital raised on admission £8 million

 

Implied market capitalisation £38.4 million (assuming full take up under the Open Offer at the Issue Price)

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

Before Admission 40.86 per cent.

Post Admission 49.58 per cent.

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

David Jeffreys Williams (Chairman)

Michael Joseph ("Mo") Stevens (Chief Executive Officer)

Robin Simon Southwell (Non-Executive Director)

Stephen Robert Ball (Non-Executive Director)

Giles Kirkley Willits (Non-Executive Director)

Christopher John Eadie (Executive Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Before Admission:

David Jeffreys Williams

18.89

Schroder Investment Management

14.01

Killik & Co

7.24

HSBC Bank plc

6.35

Tiger Brave Investments Limited

5.73

Blankstone Sington

4.38

Spreadex Limited

3.83

 

Following Admission:

David Jeffreys Williams

12.14

Schroder Investment Management

11.23

Andrew Kemshall

9.32

Steven Watts

9.32

Hargreave Hale

6.38

Killik & Co

5.08

Columbia Threadneedle

4.79

HSBC Bank plc

3.64

Tiger Brave Investments

3.28

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

None

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) 31 March

 

(ii) Target's information to 31 December 2016. Shearwater financial information up to interim results to 30 September 2016 is incorporated by reference.

 

(iii) Annual report for the year ended 31 March 2017 published by 30 September 2017. Half year report for the six months ended 30 September 2017 published by 31 December 2017. Annual report for the year ended 31 March 2018 published by 30 September 2018.

 

EXPECTED ADMISSION DATE:

9 May 2017

 

NAME AND ADDRESS OF NOMINATED ADVISER:

WH Ireland Limited

24 Martin Lane

London EC4R 0DR

 

NAME AND ADDRESS OF BROKER:

WH Ireland Limited

24 Martin Lane

London EC4R 0DR

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

Not applicable

 

DATE OF NOTIFICATION:

24 April 2017

 

NEW/ UPDATE:

New

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAABLGDSSSDBGRB
Date   Source Headline
18th May 20261:25 pmRNSAIM Rule 17 and Schedule 2(g)
29th Apr 20267:00 amRNSc.£1.8m contract win with major UK telco
1st Apr 20267:00 amRNSBoard Update
26th Mar 20265:17 pmRNSNotification of major holdings
17th Mar 20267:00 amRNSInterim Results
17th Mar 20267:00 amRNSInterim Results
12th Mar 20267:00 amRNS£1.3m contract win with major UK telco
3rd Mar 20267:00 amRNSNotice of Results and Investor Presentation
3rd Feb 20267:00 amRNSc.£9m Contract renewal and expansion
30th Jan 20261:12 pmRNSTotal Voting Rights
15th Jan 20267:00 amRNSBoard Update
23rd Dec 20257:00 amRNSContract Expansion
23rd Dec 20257:00 amRNSContract Expansion
16th Dec 202511:09 amRNSResult of AGM
10th Dec 20257:00 amRNSBlock Admission
4th Dec 20257:00 amRNS£7.3m Contract Extension
24th Nov 20257:00 amRNSNotice of AGM
18th Nov 202510:12 amRNSDirector share purchases
11th Nov 20257:00 amRNSResults for the 15-month period ended 30 June 2025
30th Oct 20257:00 amRNSNotice of Results and Presentation
21st Jul 20253:45 pmRNSIssue of New Shares to Shearwater Group Plc
11th Jul 20259:40 amRNSNotification of major holdings
10th Jul 202510:00 amRNSGrant of LTIP Options
9th Jul 20257:00 amRNSFY25 Trading Update
29th May 20254:17 pmRNSNotification of major holdings
28th May 20257:00 amRNS-RSWG company achieves landmark AI Certification
7th May 20257:00 amRNS£4.4m New Contract Win
2nd Apr 20257:00 amRNSContract Renewal
19th Feb 20253:56 pmRNSDirector dealing
17th Feb 20252:32 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSUpdate re Spanish Gold Licences
30th Jan 20257:00 amRNSChange of Year End and Grant of LTIP options
20th Dec 20247:00 amRNS£2.3m Contract wins
26th Nov 20247:00 amRNSInterim Results
20th Nov 20247:00 amRNSNotice of Investor Presentation
7th Nov 20247:00 amRNSContract Wins and Notice of Results
25th Sep 20243:59 pmRNSBoard Update
29th Aug 20245:42 pmRNSNotice of AGM and Posting of Annual Report
27th Aug 20247:00 amRNSCFO Appointment
24th Jul 20247:00 amRNSResults for the year ended 31 March 2024
19th Jul 202412:43 pmRNSContract Win and Notice of Results
3rd Apr 20247:00 amRNSFY24 Trading Update
4th Jan 20247:00 amRNSContract Wins
22nd Nov 20237:00 amRNSInterim Results
21st Nov 202311:18 amRNSChange of Nominated Adviser and Broker
20th Nov 20231:19 pmRNSBoard Update
3rd Nov 202310:12 amRNSNotice of Results and Board Appointment
10th Oct 20237:00 amRNSInterim CFO Appointment
5th Sep 20237:00 amRNSFinal Results
25th Aug 20237:00 amRNSUpdate re FY23 Results and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.